Interestingly, the presence of TH1-polarised CD4+ T cells in the peripheral circulation has been found to be indicative of good prognosis in patients with non-small cell lung cancer (NSCLC) (Laheurte et al. 2019) or CRC (Ling et al. 2016). This evidence concerns the gene CD4 and non-small cell lung carcinoma.